Keywords: Bristol-Myers Squibb, Roche, Yervoy, Vemurafenib, Metastataic melanoma

Bristol-Myers Squibb and Roche link to test Yervoy and vemurafenib for melanoma

Article | 03 June 2011

Print This

US drug major Bristol-Myers Squibb (NYSE: BMY) has joined forces with Swiss major Roche (SIX: ROG) to evaluate the utility ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in